Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Pharmacol Res. 2017 Jan 25;119:89–98. doi: 10.1016/j.phrs.2017.01.024

Fig. 5. Cellular localization of ABCG2 before and after treatment with cabozantinib.

Fig. 5

The localization of ABCG2 after treatment with cabozantinib at 5 μM on H460 parental and H460/MX20 cells overexpressing ABCG2. Scale bar, 20 μm for 72 h.